Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer

M Ming Lei (State Key Laboratory of Chemical Resource Engineering, Institute of Computational Chemistry, College of Science) M Michael J. Overman J Jin Yao (School of Management, Shenzhen Polytechnic University) T Thierry André S Sara Lonardi H Heinz-Josef Lenz M Massimo Aglietta F Fabio Gelsomino R Ray McDermott K Ka Yeung Mark Wong M Michael A. Morse (Division of Medical Oncology Department of Medicine Duke University Medical Center Durham North Carolina USA) E Eric Van Cutsem (University Hospitals Gasthuisberg, Leuven, Belgium) A Alain Hendlisz D Dana B. Cardin B Bart Neyns A Andrew Hill (Bulmore Consulting) A Anuradha Krishnamurthy F Franklin Chen S Samith Kochuparambil R Robert R. Jenq (Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, The University of Texas MD Anderson Cancer Center) S Sandzhar Abdullaev B Beilei He R Ruslan Novosiadly S Scott Kopetz (University of Texas M.D. Anderson Cancer Center, Houston)